Safety of fenbendazole in Chinese ring-necked pheasants (Phasianus colchicus)

R. Griffith, M. Yaeger, S. Hostetter, Lisa A Tell, S. Wetzlich, T. Vickroy, B. Lillie, W. MacFarlane, T. Laudenslager, E. Whitley, R. Dzikamunhenga, W. Larson

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Ring-necked pheasants raised on propagation farms can be severely parasitized with Syngamus trachea (gapeworm) and other parasitic worms. Fenbendazole is a highly effective benzimidazole-class anthelmintic that is not currently approved for game bird species in the United States. The objective of this work was to provide target animal safety data to support a label claim for fenbendazole in pheasants at 100 parts per million (ppm) in the feed for 7 consecutive days. Demonstration of safety in young pheasants and a separate demonstration of reproductive safety in adult birds were required. In the young bird study, 160 Chinese ring-necked pheasants (Phasianus colchicus, 80 males and 80 females) were fed a commercial game bird starter ration containing no antibiotics, growth promoters, or coccidiostats until day 0 of the study (approximately 21 days of age). On day 0 the birds were placed on their respective study diets containing fenbendazole at 0, 100, 300, and 500 ppm for 21 days (three times the normal treatment duration). Clinical observations were recorded twice daily. Feed consumption, feed conversion rate, and body weights were determined for each pen. Three birds from each pen were randomly selected for necropsy, histopathology, and clinical pathology. Birds were carefully examined for feathering abnormalities immediately following euthanasia. The remaining birds in each pen were submitted for drug concentration analysis so that concentrations (for low vs. high treatment levels) could be correlated with clinical observations, clinical pathology, and histologic findings. There no morbidities or mortalities after study day-1. There were no statistically significant treatment-related differences in feed consumption, feed conversion rates, body weights, serum biochemistry profiles, hematologic profiles, gross necropsy findings, histopathologic examination, and feathering. Allowable liver and muscle concentrations of fenbendazole sulfone in turkeys are 6 and 2 ppm, respectively, with a 6-hr feed withdrawal. Analysis of fenbendazole concentrations in kidney, liver, leg/thigh, and breast muscle and skin with associated fat revealed that, even at the highest dose level used and with no feed withdrawal, fenbendazole concentrations were relatively low in these tissues. These findings indicate that fenbendazole has a relatively wide margin of safety in young pheasants and that the proposed dose of 100 ppm in the feed for 7 consecutive days is well within the margin of safety. In the reproductive safety study, two large game bird farms fed fendbendazole at 100 ppm for 7 days and collected data on hatching percentage of pheasant eggs before and after treatment. Reproductive performance in hen pheasants was not adversely affected.

Original languageEnglish (US)
Pages (from-to)8-15
Number of pages8
JournalAvian Diseases
Volume58
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Fenbendazole
Phasianus colchicus
fenbendazole
Birds
pheasants
Safety
game birds
birds
margin of safety
feed deprivation
Clinical Pathology
necropsy
Syngamus
feed conversion
feed intake
Coccidiostats
trachea (vertebrates)
farms
liver
coccidiostats

Keywords

  • fenbendazole
  • gapeworm
  • pheasants
  • Safe-Guard
  • Syngamus trachea

ASJC Scopus subject areas

  • Animal Science and Zoology
  • Food Animals
  • Immunology and Microbiology(all)

Cite this

Griffith, R., Yaeger, M., Hostetter, S., Tell, L. A., Wetzlich, S., Vickroy, T., ... Larson, W. (2014). Safety of fenbendazole in Chinese ring-necked pheasants (Phasianus colchicus). Avian Diseases, 58(1), 8-15. https://doi.org/10.1637/10479-010213-Reg.1

Safety of fenbendazole in Chinese ring-necked pheasants (Phasianus colchicus). / Griffith, R.; Yaeger, M.; Hostetter, S.; Tell, Lisa A; Wetzlich, S.; Vickroy, T.; Lillie, B.; MacFarlane, W.; Laudenslager, T.; Whitley, E.; Dzikamunhenga, R.; Larson, W.

In: Avian Diseases, Vol. 58, No. 1, 2014, p. 8-15.

Research output: Contribution to journalArticle

Griffith, R, Yaeger, M, Hostetter, S, Tell, LA, Wetzlich, S, Vickroy, T, Lillie, B, MacFarlane, W, Laudenslager, T, Whitley, E, Dzikamunhenga, R & Larson, W 2014, 'Safety of fenbendazole in Chinese ring-necked pheasants (Phasianus colchicus)', Avian Diseases, vol. 58, no. 1, pp. 8-15. https://doi.org/10.1637/10479-010213-Reg.1
Griffith, R. ; Yaeger, M. ; Hostetter, S. ; Tell, Lisa A ; Wetzlich, S. ; Vickroy, T. ; Lillie, B. ; MacFarlane, W. ; Laudenslager, T. ; Whitley, E. ; Dzikamunhenga, R. ; Larson, W. / Safety of fenbendazole in Chinese ring-necked pheasants (Phasianus colchicus). In: Avian Diseases. 2014 ; Vol. 58, No. 1. pp. 8-15.
@article{2d27bde8bd684451885c9b814292b322,
title = "Safety of fenbendazole in Chinese ring-necked pheasants (Phasianus colchicus)",
abstract = "Ring-necked pheasants raised on propagation farms can be severely parasitized with Syngamus trachea (gapeworm) and other parasitic worms. Fenbendazole is a highly effective benzimidazole-class anthelmintic that is not currently approved for game bird species in the United States. The objective of this work was to provide target animal safety data to support a label claim for fenbendazole in pheasants at 100 parts per million (ppm) in the feed for 7 consecutive days. Demonstration of safety in young pheasants and a separate demonstration of reproductive safety in adult birds were required. In the young bird study, 160 Chinese ring-necked pheasants (Phasianus colchicus, 80 males and 80 females) were fed a commercial game bird starter ration containing no antibiotics, growth promoters, or coccidiostats until day 0 of the study (approximately 21 days of age). On day 0 the birds were placed on their respective study diets containing fenbendazole at 0, 100, 300, and 500 ppm for 21 days (three times the normal treatment duration). Clinical observations were recorded twice daily. Feed consumption, feed conversion rate, and body weights were determined for each pen. Three birds from each pen were randomly selected for necropsy, histopathology, and clinical pathology. Birds were carefully examined for feathering abnormalities immediately following euthanasia. The remaining birds in each pen were submitted for drug concentration analysis so that concentrations (for low vs. high treatment levels) could be correlated with clinical observations, clinical pathology, and histologic findings. There no morbidities or mortalities after study day-1. There were no statistically significant treatment-related differences in feed consumption, feed conversion rates, body weights, serum biochemistry profiles, hematologic profiles, gross necropsy findings, histopathologic examination, and feathering. Allowable liver and muscle concentrations of fenbendazole sulfone in turkeys are 6 and 2 ppm, respectively, with a 6-hr feed withdrawal. Analysis of fenbendazole concentrations in kidney, liver, leg/thigh, and breast muscle and skin with associated fat revealed that, even at the highest dose level used and with no feed withdrawal, fenbendazole concentrations were relatively low in these tissues. These findings indicate that fenbendazole has a relatively wide margin of safety in young pheasants and that the proposed dose of 100 ppm in the feed for 7 consecutive days is well within the margin of safety. In the reproductive safety study, two large game bird farms fed fendbendazole at 100 ppm for 7 days and collected data on hatching percentage of pheasant eggs before and after treatment. Reproductive performance in hen pheasants was not adversely affected.",
keywords = "fenbendazole, gapeworm, pheasants, Safe-Guard, Syngamus trachea",
author = "R. Griffith and M. Yaeger and S. Hostetter and Tell, {Lisa A} and S. Wetzlich and T. Vickroy and B. Lillie and W. MacFarlane and T. Laudenslager and E. Whitley and R. Dzikamunhenga and W. Larson",
year = "2014",
doi = "10.1637/10479-010213-Reg.1",
language = "English (US)",
volume = "58",
pages = "8--15",
journal = "Avian Diseases",
issn = "0005-2086",
publisher = "American Association of Avian Pathologists",
number = "1",

}

TY - JOUR

T1 - Safety of fenbendazole in Chinese ring-necked pheasants (Phasianus colchicus)

AU - Griffith, R.

AU - Yaeger, M.

AU - Hostetter, S.

AU - Tell, Lisa A

AU - Wetzlich, S.

AU - Vickroy, T.

AU - Lillie, B.

AU - MacFarlane, W.

AU - Laudenslager, T.

AU - Whitley, E.

AU - Dzikamunhenga, R.

AU - Larson, W.

PY - 2014

Y1 - 2014

N2 - Ring-necked pheasants raised on propagation farms can be severely parasitized with Syngamus trachea (gapeworm) and other parasitic worms. Fenbendazole is a highly effective benzimidazole-class anthelmintic that is not currently approved for game bird species in the United States. The objective of this work was to provide target animal safety data to support a label claim for fenbendazole in pheasants at 100 parts per million (ppm) in the feed for 7 consecutive days. Demonstration of safety in young pheasants and a separate demonstration of reproductive safety in adult birds were required. In the young bird study, 160 Chinese ring-necked pheasants (Phasianus colchicus, 80 males and 80 females) were fed a commercial game bird starter ration containing no antibiotics, growth promoters, or coccidiostats until day 0 of the study (approximately 21 days of age). On day 0 the birds were placed on their respective study diets containing fenbendazole at 0, 100, 300, and 500 ppm for 21 days (three times the normal treatment duration). Clinical observations were recorded twice daily. Feed consumption, feed conversion rate, and body weights were determined for each pen. Three birds from each pen were randomly selected for necropsy, histopathology, and clinical pathology. Birds were carefully examined for feathering abnormalities immediately following euthanasia. The remaining birds in each pen were submitted for drug concentration analysis so that concentrations (for low vs. high treatment levels) could be correlated with clinical observations, clinical pathology, and histologic findings. There no morbidities or mortalities after study day-1. There were no statistically significant treatment-related differences in feed consumption, feed conversion rates, body weights, serum biochemistry profiles, hematologic profiles, gross necropsy findings, histopathologic examination, and feathering. Allowable liver and muscle concentrations of fenbendazole sulfone in turkeys are 6 and 2 ppm, respectively, with a 6-hr feed withdrawal. Analysis of fenbendazole concentrations in kidney, liver, leg/thigh, and breast muscle and skin with associated fat revealed that, even at the highest dose level used and with no feed withdrawal, fenbendazole concentrations were relatively low in these tissues. These findings indicate that fenbendazole has a relatively wide margin of safety in young pheasants and that the proposed dose of 100 ppm in the feed for 7 consecutive days is well within the margin of safety. In the reproductive safety study, two large game bird farms fed fendbendazole at 100 ppm for 7 days and collected data on hatching percentage of pheasant eggs before and after treatment. Reproductive performance in hen pheasants was not adversely affected.

AB - Ring-necked pheasants raised on propagation farms can be severely parasitized with Syngamus trachea (gapeworm) and other parasitic worms. Fenbendazole is a highly effective benzimidazole-class anthelmintic that is not currently approved for game bird species in the United States. The objective of this work was to provide target animal safety data to support a label claim for fenbendazole in pheasants at 100 parts per million (ppm) in the feed for 7 consecutive days. Demonstration of safety in young pheasants and a separate demonstration of reproductive safety in adult birds were required. In the young bird study, 160 Chinese ring-necked pheasants (Phasianus colchicus, 80 males and 80 females) were fed a commercial game bird starter ration containing no antibiotics, growth promoters, or coccidiostats until day 0 of the study (approximately 21 days of age). On day 0 the birds were placed on their respective study diets containing fenbendazole at 0, 100, 300, and 500 ppm for 21 days (three times the normal treatment duration). Clinical observations were recorded twice daily. Feed consumption, feed conversion rate, and body weights were determined for each pen. Three birds from each pen were randomly selected for necropsy, histopathology, and clinical pathology. Birds were carefully examined for feathering abnormalities immediately following euthanasia. The remaining birds in each pen were submitted for drug concentration analysis so that concentrations (for low vs. high treatment levels) could be correlated with clinical observations, clinical pathology, and histologic findings. There no morbidities or mortalities after study day-1. There were no statistically significant treatment-related differences in feed consumption, feed conversion rates, body weights, serum biochemistry profiles, hematologic profiles, gross necropsy findings, histopathologic examination, and feathering. Allowable liver and muscle concentrations of fenbendazole sulfone in turkeys are 6 and 2 ppm, respectively, with a 6-hr feed withdrawal. Analysis of fenbendazole concentrations in kidney, liver, leg/thigh, and breast muscle and skin with associated fat revealed that, even at the highest dose level used and with no feed withdrawal, fenbendazole concentrations were relatively low in these tissues. These findings indicate that fenbendazole has a relatively wide margin of safety in young pheasants and that the proposed dose of 100 ppm in the feed for 7 consecutive days is well within the margin of safety. In the reproductive safety study, two large game bird farms fed fendbendazole at 100 ppm for 7 days and collected data on hatching percentage of pheasant eggs before and after treatment. Reproductive performance in hen pheasants was not adversely affected.

KW - fenbendazole

KW - gapeworm

KW - pheasants

KW - Safe-Guard

KW - Syngamus trachea

UR - http://www.scopus.com/inward/record.url?scp=84896358026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896358026&partnerID=8YFLogxK

U2 - 10.1637/10479-010213-Reg.1

DO - 10.1637/10479-010213-Reg.1

M3 - Article

VL - 58

SP - 8

EP - 15

JO - Avian Diseases

JF - Avian Diseases

SN - 0005-2086

IS - 1

ER -